drugset / Trial / NCT04203862

A Study of NPC-22 in Healthy Adult Males

NCT04203862 ↗

Phase 1 Completed 40 enrolled Nobelpharma
RandomizedSequentialQuadruple-blindBasic science

Summary

The purpose of this trial is to examine the safety and pharmacokinetics of NPC-22 administered in a single ascending dose in healthy adult males.

Timeline

Start
2019-11-19
Primary completion
2020-02-04
Completion
2020-02-04

Drugs

EvaluationDrugModalityDoseRoute
Subject NPC-22 Unknown — —

Indications

No indication recorded.